X-ray diffraction II: Using single-crystal X-ray diffraction to study polymorphism and solvatomorphism

Pharmaceutical Technology

Volumn 24, Issue 9, 2000, Pages 116-125

  Brittain, H G ^a  

^a Center for Pharmaceutical Physics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOLVENT; WATER;

CHEMICAL STRUCTURE; CONFORMATION; CRYSTAL STRUCTURE; CRYSTALLIZATION; CRYSTALLOGRAPHY; PHARMACEUTICS; REVIEW; SOLVATION; X RAY DIFFRACTION;

EID: 0033800674     PISSN: 01478087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. X-ray diffraction I: On the diffraction of X-rays by crystalline solids
2. Crystal polymorphism of pharmaceuticals
3. Review on crystal polymorphism of substances in the European pharmacopoeia
4. The structure of resorcinol: A quantitative X-ray investigation
5. A new form of Resorcinol. I. Structure determination by X-rays
6. Structures of two conformational polymorphs of the cholesterol-lowering drug probucol
7. Thermochemistry and conformational polymorphism of a hexamorphic crystal system
8. Hydrates
9. The structures of ampicillin: A comparison of the anhydrate and trihydrate forms
10. Physicochemical characterization of diclofenac N-(2-hydroxymethyl)pyrrolidine: Anhydrate and dihydrate crystalline forms
11. A novel clathrate design: Selective inclusion of uncharged molecules via the binaphthyl hinge and appended coordinated groups. X-ray crystal structures and binding modes of 1,1'-binaphytyl-2,2'-dicarboxylic acid host/hydroxylic guest inclusions
12. Pseudo-dimorphism of complexes between 1,1'-binaphythyl-2,2'-dicarboxylic acid and ethanol: X-ray crystal structures of the β-form and of the unsolvated host compound